AfriqVax was incorporated partly in response to the African Union ambitious goal, to have manufacturers based on the continent develop, produce, and supply more than 60% of the vaccine doses required on the continent by 2040. Also, Nigeria being the most populous country in Africa exploring local manufacture of some of the routine vaccines as a sustainable exit strategy from Global Alliance for Vaccination and Immunization (GAVI) support.
